Ieke B. Ginjaar

Leiden University Medical Center

Papers

1

Total Citations

55

H-Index

1

About

Dr. Ieke B. Ginjaar is a leading molecular geneticist whose research has fundamentally advanced the understanding and diagnosis of Duchenne and Becker muscular dystrophies (DMD/BMD). Her primary focus lies in unraveling the complex mutational landscape of the dystrophin gene, the root cause of these devastating neuromuscular disorders. Dr. Ginjaar’s major contributions include pioneering the use of denaturing gradient gel electrophoresis (DGGE) for whole-gene mutation scanning, a technique that proved critical for identifying small mutations in the 30-35% of DMD patients who lack large deletions or duplications. Her landmark 2003 paper on this approach, which has garnered 55 citations, remains a cornerstone in the field. This work, alongside her broader efforts, has enabled more precise genetic diagnoses, carrier detection, and prenatal testing, directly impacting patient care and family counseling. By systematically characterizing the full spectrum of dystrophin mutations, Dr. Ginjaar has provided essential tools for genotype-phenotype correlations and laid critical groundwork for emerging mutation-specific therapies, solidifying her reputation as a key architect in the molecular diagnostics of muscular dystrophy.

Research Focus

Key Achievements

1
H-Index
1
Papers
55
Total Citations
55
Avg Citations/Paper
🏆 Most Cited Paper
DGGE-based whole-gene mutation scanning of the dystrophin gene in Duchenne and Becker muscular dystrophy patients
55 citations · 2003
📈 Most Prolific Year: 2003 (1 Papers)
🤝 Key Collaborators: 11
🏛 Institutions: Leiden University Medical Center

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago